{
  "thread": {
    "uuid": "5e1cde1709a65f39d68b530386ea3f1c0af022bd",
    "url": "https://finance.eastmoney.com/a/202507313472499410.html",
    "site_full": "finance.eastmoney.com",
    "site": "eastmoney.com",
    "site_section": "http://finance.eastmoney.com/",
    "site_categories": [
      "financial_news",
      "finance"
    ],
    "section_title": "财经首页 - 东方财富网",
    "site_title": null,
    "title": "振东制药：参股公司在研药品Ⅲ期临床试验达到主要研究终点 _ 东方财富网",
    "title_full": "振东制药：参股公司在研药品Ⅲ期临床试验达到主要研究终点 _ 东方财富网",
    "published": "2025-07-31T06:49:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 2186,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "5e1cde1709a65f39d68b530386ea3f1c0af022bd",
  "url": "https://finance.eastmoney.com/a/202507313472499410.html",
  "ord_in_thread": 0,
  "author": "武斌",
  "published": "2025-07-31T06:49:00.000+03:00",
  "title": "振东制药：参股公司在研药品Ⅲ期临床试验达到主要研究终点 _ 东方财富网",
  "text": "上证报中国 证券 网讯 7月30日晚 振东制药 发布公告称，公司参股的广东龙创基药业有限公司（以下简称“龙创基药业”）在研项目“阴道用乳杆菌二联活菌胶囊”的Ⅲ期临床试验达到主要研究终点。公司近期将递交上市许可申请前的沟通交流申请，积极推进胶囊上市进程。\n　　根据公告，该胶囊为复方制剂，主要成分为格氏乳杆菌和鼠李糖乳杆菌活菌，用于由菌群紊乱而引起的细菌性阴道病的治疗。相比传统抗生素治疗方案，具有差异化优势，存在显著未满足的临床需求，未来市场潜力较大。\n　　对此， 振东制药 表示，近期将就“阴道用乳杆菌二联活菌胶囊”治疗细菌性阴道病适应证向国家药品监督管理局药品审评中心递交上市许可申请前的沟通交流申请，积极推进上市进程。\n　　据悉，2024年1月 振东制药 决定增资龙创基药业获得其6.015%的股权，后续龙创基药业取得“阴道用乳杆菌二联活菌胶囊”生产批件，振东制药有权在其取得“阴道用乳杆菌二联活菌胶囊”生产批件后，受让强基药业持有的龙创基药业53.985%的股权，合计达60%股权。\n　　华福 证券 最新研报表示，龙创基药业的乳杆菌二联活菌治疗细菌性阴道病领域的研发进度处于行业领先，预计2025年有望读出3期数据并申请上市，成为全球近20年来获批上市的首个双联活菌制剂。\n（文章来源：上海 证券 报·中国证券网）",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology",
    "Economy, Business and Finance"
  ],
  "topics": [
    "Health->medical test",
    "Health->health treatment and procedure",
    "Health->drug rehabilitation",
    "Science and Technology->medical research",
    "Science and Technology->biomedical science",
    "Economy, Business and Finance->healthcare industry",
    "Economy, Business and Finance->business reporting and performance"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-07-31T08:06:59.762+03:00",
  "updated": "2025-07-31T08:12:23.000+03:00"
}